Clinical Trials Logo
NCT number NCT03498105
Study type Observational
Source Milton Keynes University Hospital NHS Foundation Trust
Contact Antoanela Colda
Phone 0044 1908 995136
Email antoanela.colda@mkuh.nhs.uk
Status Recruiting
Phase
Start date May 22, 2017
Completion date December 1, 2019

Clinical Trial Summary

This project is aiming to identify the diagnostic utility CEB (Cardiac Electrical Biomarker) in patients who are undergoing cardiac investigations.


Clinical Trial Description

This project is aiming to identify the diagnostic utility of an ECG derived measurement by a Medical device (Vectraplex by VectraCor ltd) in patients who are undergoing cardiac investigations. This technology is based on the principle of vector ECG and an analysing system that computes a composite score termed a Cardiac Electrical Biomarker (CEB TM).

CEB has been validated in the detection of STEMI with high sensitivity and specificity in the detection ECG changes characteristic to STEMI. The CEB may be a more accurate way of identifying heart injury and causes of chest pain compared to standard tests, which could lead to faster diagnosis and treatment of these patients.

The diagnostic utility of the CEBTM in the following:

1. Acute chest pain assessment in the A&E department.

2. Acute chest pain assessment in the Primary Care Surgery.

3. Performance of CEB during inducible ischaemia in patients with stable angina

4. Performance of CEB during acute ischaemia in patients undergoing percutaneous coronary intervention (PCI)

5. Performance of CEB in patients undergoing cardio-toxic treatment


Study Design


Related Conditions & MeSH terms